Tahara H - Search Results

1

Viral vectors for gene therapy.

Robbins PD, Tahara H, Ghivizzani SC. Robbins PD, et al. Among authors: tahara h. Trends Biotechnol. 1998 Jan;16(1):35-40. doi: 10.1016/S0167-7799(97)01137-2. Trends Biotechnol. 1998. PMID: 9470229 Review.

2

Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.

Shibata T, Uchida H, Shiroyama T, Okubo Y, Suzuki T, Ikeda H, Yamaguchi M, Miyagawa Y, Fukuhara T, Cohen JB, Glorioso JC, Watabe T, Hamada H, Tahara H. Shibata T, et al. Among authors: tahara h. Gene Ther. 2016 Jun;23(6):479-88. doi: 10.1038/gt.2016.17. Epub 2016 Feb 23. Gene Ther. 2016. PMID: 26905369

3

Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy.

Okada H, Attanucci J, Tahara H, Pollack IF, Bozik ME, Chambers WH, Lotze MT. Okada H, et al. Among authors: tahara h. Cancer Gene Ther. 2000 Mar;7(3):486-94. doi: 10.1038/sj.cgt.7700140. Cancer Gene Ther. 2000. PMID: 10766355

4

Retrovirally transduced myeloid dendritic cells expressing mammalian or viral IL-10 differentially affect cell-mediated immunity and growth of transplantable tumors.

Takayama T, Tahara H, Thomson AW. Takayama T, et al. Among authors: tahara h. Transplant Proc. 2001 Feb-Mar;33(1-2):590. doi: 10.1016/s0041-1345(00)02156-4. Transplant Proc. 2001. PMID: 11266972 No abstract available.

5

Murine models of cancer cytokine gene therapy using interleukin-12.

Tahara H, Zitvogel L, Storkus WJ, Robbins PD, Lotze MT. Tahara H, et al. Ann N Y Acad Sci. 1996 Oct 31;795:275-83. doi: 10.1111/j.1749-6632.1996.tb52677.x. Ann N Y Acad Sci. 1996. PMID: 8958939

6

Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness.

Takayama T, Nishioka Y, Lu L, Lotze MT, Tahara H, Thomson AW. Takayama T, et al. Among authors: tahara h. Transplantation. 1998 Dec 27;66(12):1567-74. doi: 10.1097/00007890-199812270-00001. Transplantation. 1998. PMID: 9884241

7

Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.

Tanaka F, Hashimoto W, Robbins PD, Lotze MT, Tahara H. Tanaka F, et al. Among authors: tahara h. Gene Ther. 2002 Nov;9(21):1480-6. doi: 10.1038/sj.gt.3301827. Gene Ther. 2002. PMID: 12378411

8

Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth.

Takayama T, Tahara H, Thomson AW. Takayama T, et al. Among authors: tahara h. Transplantation. 2001 May 15;71(9):1334-40. doi: 10.1097/00007890-200105150-00027. Transplantation. 2001. PMID: 11397973

9

Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro.

Takayama T, Morelli AE, Robbins PD, Tahara H, Thomson AW. Takayama T, et al. Among authors: tahara h. Gene Ther. 2000 Aug;7(15):1265-73. doi: 10.1038/sj.gt.3301244. Gene Ther. 2000. PMID: 10918497

10

Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.

Hiroishi K, Tüting T, Tahara H, Lotze MT. Hiroishi K, et al. Among authors: tahara h. Gene Ther. 1999 Dec;6(12):1988-94. doi: 10.1038/sj.gt.3301034. Gene Ther. 1999. PMID: 10637450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results